Cargando…

Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe((−/−)) mice

Atherosclerosis (AS) is the leading cause of heart attacks, stroke, and peripheral vascular disease. Berberine (BBR), a botanical medicine, has diversified anti-atherosclerotic effects but with poor absorption. The aim of this study was to develop an effective BBR-entrapped nano-system for treating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Xiaolei, Zhang, Tingting, Luo, Zhigang, Li, Xiaolin, Lin, Miao, Li, Rui, Du, Peng, Yu, Xiaoyou, Ma, Chen, Yan, Pengju, Su, Jin, Wang, Lulu, Li, Yuhuan, Jiang, Jiandong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564017/ https://www.ncbi.nlm.nih.gov/pubmed/33088695 http://dx.doi.org/10.1016/j.apsb.2020.03.005

Ejemplares similares

Effects of Berberine on Atherosclerosis
por: Rui, Rui, et al.
Publicado: (2021)

Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice
por: Wu, Min, et al.
Publicado: (2020)

Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy
por: Wang, Huiqiang, et al.
Publicado: (2017)

Berberine ameliorates non-alcoholic steatohepatitis in ApoE(−/−) mice
por: Yang, Jin, et al.
Publicado: (2017)

Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology
por: Xie, Xuejiao, et al.
Publicado: (2020)

Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(−/−) mice
por: Chen, Junwen, et al.
Publicado: (2014)

Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome
por: Li, Xingxing, et al.
Publicado: (2021)

Autophagic degradation of LOX-1 is involved in the maintenance of vascular integrity injured by oxLDL and protected by Berberine
por: Zheng, Yangmin, et al.
Publicado: (2023)

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
por: Yang, Shengjie, et al.
Publicado: (2021)

T Cells in Atherosclerosis in Ldlr−/− and Apoe−/− Mice
por: Getz, Godfrey S., et al.
Publicado: (2018)

Effects of Icariin on Atherosclerosis and Predicted Function Regulatory Network in ApoE Deficient Mice
por: Zhang, Yibing, et al.
Publicado: (2018)

Adoptive transfer of metabolically reprogrammed macrophages for atherosclerosis treatment in diabetic ApoE(−/-) mice
por: Wang, Tingting, et al.
Publicado: (2022)

Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice
por: Zuo, Qingjuan, et al.
Publicado: (2022)

Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE(-/-) mice by down-regulating PCSK9 via ERK1/2 pathway
por: Ma, Chun-Yan, et al.
Publicado: (2021)

Berberine activates peroxisome proliferator‐activated receptor gamma to increase atherosclerotic plaque stability in Apoe (−/−) mice with hyperhomocysteinemia
por: Li, Hongjun, et al.
Publicado: (2016)

Metoprolol Reduces Proinflammatory Cytokines and Atherosclerosis in ApoE(−/−) Mice
por: Ulleryd, Marcus A., et al.
Publicado: (2014)

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2015)

Overexpression of NgBR inhibits high-fat diet–induced atherosclerosis in ApoE-deficiency mice
por: Gong, Ke, et al.
Publicado: (2023)

Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(−/−) mice
por: Wang, Qi, et al.
Publicado: (2021)

Natural Nano-Drug Delivery System in Coptidis Rhizoma Extract with Modified Berberine Hydrochloride Pharmacokinetics
por: Zhao, Jing, et al.
Publicado: (2021)

Dosage of Dual-Protein Nutrition Differentially Impacts the Formation of Atherosclerosis in ApoE(−/−) Mice
por: Huang, Yingchun, et al.
Publicado: (2022)

Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE(-/-) mice
por: Dunér, Pontus, et al.
Publicado: (2021)

Association and Linkage Disequilibrium Analyses of APOE Polymorphisms in Atherosclerosis
por: Artieda, Marta, et al.
Publicado: (2008)

Genetic disruption of the Gipr in Apoe(−/−) mice promotes atherosclerosis
por: Pujadas, Gemma, et al.
Publicado: (2022)

Intranasal Delivery of E-Selectin Reduces Atherosclerosis in ApoE−/− Mice
por: Li, Xinhui, et al.
Publicado: (2011)

Auto-Antibody Production During Experimental Atherosclerosis in ApoE(-/-) Mice
por: Hutchinson, Mark A., et al.
Publicado: (2021)

Mechanism of microRNA regulating the progress of atherosclerosis in apoE-deficient mice
por: Lou, Xiaoqian, et al.
Publicado: (2021)

Dual-functionalised shellac nanocarriers give a super-boost of the antimicrobial action of berberine
por: Al-Obaidy, Saba S. M., et al.
Publicado: (2018)

Encapsulation of berberine decorated ZnO nano-colloids into injectable hydrogel using for diabetic wound healing
por: Yin, Xuechen, et al.
Publicado: (2022)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
por: Valanti, Eftaxia-Konstantina, et al.
Publicado: (2018)

Phosphorylcholine-Primed Dendritic Cells Aggravate the Development of Atherosclerosis in ApoE(−/−) Mice
por: Dong, Qian, et al.
Publicado: (2021)

Engineering magnetic nano-manipulators for boosting cancer immunotherapy
por: Yan, Bin, et al.
Publicado: (2022)

Activation of AMP-Activated Protein Kinase Is Required for Berberine-Induced Reduction of Atherosclerosis in Mice: The Role of Uncoupling Protein 2
por: Wang, Qilong, et al.
Publicado: (2011)

Npp1 promotes atherosclerosis in ApoE knockout mice
por: Nitschke, Yvonne, et al.
Publicado: (2011)

Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe(−/−) Mice
por: Lindskog Jonsson, Annika, et al.
Publicado: (2018)

Adipokine Chemerin Stimulates Progression of Atherosclerosis in ApoE(−/−) Mice
por: Liu, Huadong, et al.
Publicado: (2019)

Inhibition of JAK2 Suppresses Myelopoiesis and Atherosclerosis in Apoe(−/−) Mice
por: Tang, Yang, et al.
Publicado: (2020)

Identification of the atherosclerosis phenotype in vivo by vascular duplex ultrasonography in ApoE-deficient dogs
por: Jia, Lingyun, et al.
Publicado: (2021)

Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications
por: Ji, Hao, et al.
Publicado: (2021)

Dickkopf‐3 Ablation Attenuates the Development of Atherosclerosis in ApoE‐Deficient Mice
por: Cheng, Wen‐Lin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rlq5obocmd981g4npc19j7q4kp